Latest Regulatory Approvals News

Page 22 of 191
Dimerix Limited’s ACTION3 Phase 3 trial for DMX-200 in FSGS kidney disease has passed its seventh Independent Data Monitoring Committee review with no safety concerns, reinforcing the drug’s promising safety profile.
Ada Torres
Ada Torres
19 Nov 2025
Horizon Oil Limited reported robust FY25 results, highlighted by a strategic acquisition of Thailand upstream assets and a 10-year permit extension at Maari, nearly doubling production and securing a strong outlook through 2030.
Maxwell Dee
Maxwell Dee
19 Nov 2025
BCAL Diagnostics is preparing to launch its Avantect® pancreatic and ovarian cancer blood tests in Australia by January 2026, following key regulatory approvals and promising clinical data. The company also broadens the reach of its BREASTESTplus™ breast cancer test, targeting a larger segment of women with dense breast tissue.
Ada Torres
Ada Torres
19 Nov 2025
Decidr AI Industries has announced a strategic acquisition of Delaware-based Sugarwork Inc., marking its official entry into the US market and enhancing its Agentic AI platform with advanced knowledge transfer capabilities.
Sophie Babbage
Sophie Babbage
19 Nov 2025
Aquirian Limited is accelerating its growth trajectory through strategic joint ventures and a major expansion of its Wubin facility, aiming to reshape the mining services landscape with advanced drill and blast technologies.
Maxwell Dee
Maxwell Dee
19 Nov 2025
Helloworld Travel Limited has made a non-binding indicative all-cash offer to acquire the remaining shares of Webjet Group at A$0.90 per share, signaling a potential major consolidation in the online travel sector.
Victor Sage
Victor Sage
19 Nov 2025
Li-S Energy has accelerated its transition from research to manufacturing with a $7.8 million ARENA grant, new commercial partnerships, and plans for a large-scale production facility.
Maxwell Dee
Maxwell Dee
18 Nov 2025
Biotron Limited has launched a $1.5 million non-renounceable rights issue to fund its strategic acquisition of Sedarex Limited and support ongoing drug development programs. The capital raise follows shareholder approval and aims to diversify Biotron’s portfolio with a next-generation general anaesthetic.
Ada Torres
Ada Torres
18 Nov 2025
Vintage Energy has signed a conditional agreement to acquire Metgasco's 25% interest in key Southern Flank gas joint ventures, aiming to accelerate production and value creation from the Vali and Odin fields.
Maxwell Dee
Maxwell Dee
18 Nov 2025
Metgasco has agreed to sell its 25% stake in key Cooper Eromanga Basin gas fields to Vintage Energy for $5.9 million, marking a significant shift in its business focus. The deal hinges on Vintage securing funding and acquiring additional interests, with shareholder approval required.
Maxwell Dee
Maxwell Dee
18 Nov 2025
Metgasco Ltd has entered a conditional agreement to sell its 25% stake in two gas fields in the Cooper Eromanga Basin to Vintage Energy for $5.9 million, marking a significant shift in its asset portfolio.
Maxwell Dee
Maxwell Dee
18 Nov 2025
Clover Corporation Limited reported a standout FY25 with robust revenue growth and a sharp rise in profitability, underpinned by strategic market expansion and product innovation. The company’s strengthened balance sheet and optimistic FY26 outlook signal continued momentum.
Victor Sage
Victor Sage
18 Nov 2025